Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | DPEP1 | P16444 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.37 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.37 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.37 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.37 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.37 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10638498 | 1.00 | TBXAS1 (0.51) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL5173409 | 0.90 | TBXAS1 (0.58) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL6915210 | 0.85 | CYP3A4 (0.47) | TBXAS1CYP3A4CYP2C9DPEP1GRIK1 | |
| SCHEMBL2673966 | 0.83 | TBXAS1 (0.52) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL2673972 | 0.83 | TBXAS1 (0.52) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL3128764 | 0.83 | ALDH1A1 (0.53) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL5993797 | 0.83 | ALDH1A1 (0.53) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL2271804 | 0.83 | TBXAS1 (0.56) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL15056885 | 0.83 | TBXAS1 (0.52) | TBXAS1CYP3A4CYP2C9EPHX2PPARG | |
| SCHEMBL10349544 | 0.83 | ALDH1A1 (0.53) | TBXAS1CYP3A4CYP2C9EPHX2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
| CN-112384834-B | Cured film, alignment material, and retardation material | 日产化学株式会社 | 2023-08-11 | — | — | CN | disclosed |
| CN-114746512-A | Composition for forming cured film, alignment material, and phase difference material | 日产化学株式会社 | 2022-07-12 | — | — | CN | disclosed |
| CN-106980233-B | Cured film-forming composition, alignment material, and phase difference material | 日产化学工业株式会社 | 2021-07-13 | — | — | CN | disclosed |
| CN-112384834-A | Cured film, alignment material, and phase difference material | 日产化学株式会社 | 2021-02-19 | — | — | CN | disclosed |
| CN-107463066-B | Cured film-forming composition, alignment material, and phase difference material | 日产化学工业株式会社 | 2020-10-30 | — | — | CN | disclosed |
| CN-105283512-B | Composition for forming cured film, alignment material, and phase difference material | 日产化学工业株式会社 | 2018-12-11 | — | — | CN | disclosed |
| US-9823400-B2 | Cured film formation composition, orientation material, and retardation material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-11-21 | — | — | US | disclosed |
| CN-104603650-B | It is orientated manufacture method, orientation material, the manufacture method of phase difference material and the phase difference material of material | 日产化学工业株式会社 | 2017-06-06 | — | — | CN | disclosed |
| US-9598547-B2 | Cured-film formation composition, orientation material, and retardation material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-03-21 | — | — | US | disclosed |
| US-6841566-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM, LTD. (CA) | 2005-01-11 | — | — | US | disclosed |
| US-20040171626-A1 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-09-02 | — | — | US | disclosed |
| WO-2004065367-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-08-05 | — | — | WO | disclosed |
| EP-1411928-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2004-04-28 | — | — | EP | disclosed |
| US-20030236251-A1 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2003-12-25 | — | — | US | disclosed |
| WO-2003007945-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2003-01-30 | — | — | WO | disclosed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | disclosed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | disclosed |
| US-4101543-A | DYES FOR CELLULOSE ACETATES, AROMATIC POLYESTERS OR POLYAMIDES | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236251-A1 | Viral polymerase inhibitors | POLR2H, CTDSP1, POLR2E | TBXAS1 729/4885CYP3A4 624/4885CYP2C9 1400/4885 |
| US-20040171626-A1 | Viral polymerase inhibitors | POLM, MED1, POLR2H | TBXAS1 2822/4885CYP3A4 2696/4885CYP2C9 2961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.